The Gracie Fund for Pediatric Cancer can accept gifts of checks, credit card payments, appreciated stock, wire transfers or other assets. Each gift will be received and administered by the New Canaan Community Foundation on behalf of the Gracie Fund for Pediatric Cancer. All gifts will receive an acknowledgement letter for tax purposes.
Make checks payable to the New Canaan Community Foundation. Please note that "Gracie Fund for Pediatric Cancer" must go in the memo section. Checks may be mailed to:
Gracie Fund for Pediatric Cancer
c/o New Canaan Community Foundation
111 Cherry Street
New Canaan, CT 06840
Please first call the New Canaan Community Foundation at (203) 966-0231
Then provide the following account information to your advisor or brokerage:
New Canaan Community Foundation
Brokerage account #: 42529061
Vanguard contact: Michael Chance 610-669-2871
Send wire transfers to the New Canaan Community Foundation account at:
Bankwell New Canaan
208 Elm Street
New Canaan, CT 06840
ABA Routing #: 021113662
Please call the New Canaan Community Foundation at (203) 966-0231 for the account number. Be sure to notify the Foundation that the gift is for the Gracie Fund for Pediatric Cancer
Please contact the New Canaan Community Foundation at (203) 966-0231
Many companies offer matching gift programs. We encourage you to check with your employer to find out if they have a program that will match your donation. A corporate match can double or triple the impact of your gift while the donor is recognized for the full contribution.
All donations to the Gracie Fund via the Foundation are tax-deductible to the full extent allowed by law. The New Canaan Community Foundation tax ID number is 06-0970466
For other contribution related questions, please call The New Canaan Community Foundation at (203) 966-0231 or e-mail email@example.com
Children suffering with cancer face so many challenges and need to overcome so many difficulties. Their families and the medical professionals that treat them see and feel those difficulties as well. There are therapies, supports and services that can help in making a child well or making a child at least feel a bit better. Unfortunately, sometimes the resources needed to access these therapies, supports and services are not available.
Contributions raised from the New Canaan Combine will go to establishing a fund at Yale Children's Hospital, under the supervision of Dr. Stephanie Massaro, that will directly benefit children with cancer. We intend that these funds will be used in a rapid reaction fashion for unmet needs.
These funds will NOT be co-mingled. These funds will NOT incur heavy administration fees or other friction costs. These funds WILL will be used directly for the benefit of children suffering with cancer and for those people and efforts that are saving their lives.
Some of the immediate uses of the money we raise:
- Patient care and quality of life improvements. This will include many types of patient supports and integrative approaches to pediatric medicine
- Research, education & training. This may include various science endeavors such as helping to ensure access to early phase clinical trials for patients
Dr. Massaro is the medical director of the Pediatric Hematology/Oncology in-patient unit and director of the Pediatric Palliative and Hospice Care Programs at Yale-New Haven Children's Hospital. Dr. Massaro is also an associate professor at Yale University School of Medicine and has clinical and research interests that encompass the diagnosis and treatment of pediatric blood cancers including Leukemia and Lymphoma. Dr. Massaro volunteers her time and effort generously for cancer charities. She is a mom and she is saving Gracie's life.
Our experience dealing with this disease from the patient and family perspective will guide the deployment of contributed funds. Doctor Massaro's involvement, however, really takes the effectiveness of each dollar to an entirely new level. As someone that is in the trenches everyday, Dr. Massaro will help identify where the funds are most urgently needed.